Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system
Related Experiment Video
Updated: Aug 9, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Kasandra J-L Riley1, Laura A Cassiday, Akash Kumar
1Department of Biochemistry and Molecular Biology, Guggenheim 16, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota 55905, USA.
Abstract:
The p53 tumor suppressor protein is a homotetrameric transcription factor whose gene is mutated in nearly half of all human cancers. In an unrelated screen of RNA/protein interactions using the yeast three-hybrid system, we inadvertently detected p53 interactions with several different RNAs. A literature review revealed previous reports of both sequence-specific and -non-specific interactions between p53 and RNA. Using yeast three-hybrid selections to identify preferred RNA partners for p53, we failed to identify primary RNA sequences or obvious secondary structures required for p53 binding. The cationic p53 C-terminus was shown to be required for RNA binding in yeast. We show that while p53 strongly discriminates between certain RNAs in the yeast three-hybrid assay, the same RNAs are bound equally by p53 in vitro. We further show that the p53 RNA-binding preferences in yeast are mirrored almost exactly by a recombinant tetrameric form of the HIV-1 nucleocapsid (NC) protein thought to be a sequence-nonspecific RNA-binding protein. However, the possibility of specific RNA binding by p53 could not be ruled out because p53 and HIV-1 NC displayed certain differences in RNA-binding preference. We conclude that (1) p53 binds RNA in vivo, (2) RNA binding by p53 is largely sequence-nonspecific in the yeast nucleus, (3) some structure-specific RNA binding by p53 cannot be ruled out, and (4) caution is required when interpreting results of RNA screens in the yeast three-hybrid system because sequence-dependent differences in RNA folding and display can masquerade as sequence-dependent differences in protein recognition.
Insights
The tumor suppressor protein p53 binds RNA in vivo, largely in a sequence-nonspecific manner within the yeast nucleus. Caution is advised when using yeast three-hybrid systems for RNA-binding studies.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- The p53 protein is a crucial tumor suppressor, frequently mutated in human cancers.
- Previous studies suggest both sequence-specific and non-specific interactions between p53 and RNA.
- RNA-binding proteins play diverse roles in gene regulation and cellular processes.
Purpose of the Study:
- To investigate the nature of RNA interactions with the p53 protein.
- To identify specific RNA sequences or structures preferred by p53.
- To evaluate the reliability of the yeast three-hybrid system for studying p53-RNA interactions.
Main Methods:
- Utilized the yeast three-hybrid system for screening RNA/protein interactions.
- Performed in vitro binding assays with p53 and various RNAs.
- Compared p53 RNA-binding preferences with those of the HIV-1 nucleocapsid (NC) protein.
Main Results:
- p53 was found to interact with multiple RNAs in vivo.
- RNA binding by p53 in yeast was largely sequence-nonspecific, with the cationic C-terminus being crucial.
- In vitro assays showed less discrimination between RNAs compared to the yeast system.
- p53's RNA-binding preferences in yeast mirrored those of HIV-1 NC, a known non-specific binder.
Conclusions:
- p53 binds RNA in vivo, and this interaction is predominantly sequence-nonspecific in the yeast nucleus.
- While structure-specific binding cannot be entirely excluded, yeast three-hybrid results require careful interpretation due to RNA folding artifacts.
- The study highlights potential limitations of yeast-based screens for characterizing protein-RNA interactions.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Experimental RNAi

